Does Dr. JILL BUCKTHAL-MCCUIN have financial conflicts of interest?

Dr. JILL BUCKTHAL-MCCUIN (MD) has received a total of $10,416 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $10,416 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JILL BUCKTHAL-MCCUIN?

According to CMS Open Payments data, Dr. JILL BUCKTHAL-MCCUIN received funding from ABBVIE ($1,716), LILLY USA ($1,158), and NOVARTIS PHARMACEUTICALS CORPORATION ($725).

Does Dr. JILL BUCKTHAL-MCCUIN receive research grants or speaking fees?

Dr. JILL BUCKTHAL-MCCUIN has received $10,416 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JILL BUCKTHAL-MCCUIN

MDReal-Time Hydrated

Specialty: Dermatology, Dermatopathology

Practice Location: GREENSBORO, GA 30642

NPI Number: 1780803098

LIFETIME INDUSTRY VALUE

$10,416

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BUCKTHAL-MCCUIN is a verified Dermatology, Dermatopathology practitioner based in GREENSBORO, GA.

Between 2021 and 2025, Dr. BUCKTHAL-MCCUIN had an overall industry promotional and research financial footprint of $10,416 as recorded in the federal CMS Open Payments database.

$10,416 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BUCKTHAL-MCCUIN's primary funding source is ABBVIE, which accounts for $1,716 (representing 16.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBVIE

Rank 1

$1,716

16.5%

LILLY USA

Rank 2

$1,158

11.1%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 3

$725

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.